AnaCardio AB announced that it has received SEK 150 million in a round of funding led by Flerie Invest AB, and Industrifonden on September 7, 2022. The transaction also included participation from 3B Health Ventures, returning investors Karolinska Development AB , and individual investors Fredrik and Ann-Helene Ljungström.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.65 SEK | -1.20% | +5.10% | -2.83% |
Apr. 26 | Karolinska Development AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 16 | Karolinska Development AB Announces That Björn Cochlovius Has Declined Re-Election | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-2.83% | 41.68M | |
-4.98% | 182B | |
+2.84% | 112B | |
-2.68% | 68.58B | |
+4.53% | 51.58B | |
+8.00% | 44.24B | |
+9.65% | 43.65B | |
+25.30% | 32.46B | |
-0.17% | 25.61B | |
+21.57% | 25.99B |
- Stock Market
- Equities
- KDEV Stock
- News Karolinska Development AB
- AnaCardio AB announced that it has received SEK 150 million in funding from Industrifonden, Karolinska Development AB, Flerie Invest AB, and other investors